INCATE update #2 – AMR conference prize, awards round 2, new partners and sign up to the first entrepreneurs club!
Congratulations to LimmaTech Biologics AG for the AMR Conference prize
We are very happy to share that the team from Limmatech won the first INCATE startup prize at the AMR Conference in April. The prize of 10,000 euros was provided by our partner Vossius. The AMR Conference audience selected the winner with over 140 people voting. Laura Yates from Limmatech was selected from 10 fantastic pitches. If you missed it, the full pitch session is available here. Each of the teams were provided with a recording of their pitch which they can use for their own purposes.
© eventfotografen.com/BIOCOM AG
Selection Committee award round 2
The INCATE Selection Committee has also been busy awarding two additional ventures Stage I support. The two companies are
- Tabrix – Developing novel anti-virulence agents for multi drug resistant TB and difficult to treat infectious diseases
- Enzoxa – An innovative and selective treatment against stomach diseases caused by Helicobacter pylori
We look forward to working together with these promising academic groups as they become entrepreneurs driving their projects forward. You can see the whole INCATE portfolio here.
Join the first INCATE Entrepreneurs Club on July 7th!
Marc Gitzinger will join the first Entrepreneurs Club share their experience with INCATE entrepreneurs in a fireside chat format and then we would like to hear from you what should be discussed in the INCATE entrepreneurs club. Register here.
INCATE relies on supporting partners to provide expert advice and support where needed. IHMA and Vossius are two partners to highlight.
Vossius who sponsored the pitching event at the AMR Conference are one of Europe’s leading intellectual property firms. If you would be interested in a non-binding first discussion please don`t hesitate to contact Phillip Marchand for large molecules and general questions or Oswin Ridderbusch for small molecules, repurposing and platforms.
IHMA is a global laboratory and consultative-based company (with locations in Monthey, Switzerland, Schaumburg, Il, USA, Shanghai, China and Gurugram, India) specializing in supporting the discovery and development of anti-infective products needed to combat infectious diseases. For more information please contact Darcie Carpenter or Stephen Hawser.
Hear first hand about INCATE
Here is a short video from startups, supporters and industry and academic partners who are part of INCATE. Hear what they hope to see from INCATE.
INCATE has quarterly calls, please get in touch if you have a promising academic project or early stage start-up at email@example.com
If you would like to help the INCATE team in the fight against drug-resistant bacterial infections (e.g. through expert advice on R&D or support with funding) please get in contact at the same address.
If you received this email as a forward from a contact – please sign-up to the INCATE community here to receive future emails. www.incate.net/SIGNUP